Learn how ECG noise filtering that adapts to noise type improved QT and QRS accuracy and supports more reliable cardiac ...

Researchers developed an AI model to detect myocardial ischemia and coronary microvascular and vasomotor dysfunction using ...

The trial’s primary efficacy endpoint is AF burden, which refers to the percentage of time a participant is in AF.

Mount Sinai analysis looks at the effectiveness of electrocardiograms analyzed via deep learning as a tool for early COPD detection ...

Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality globally. Effective management ...

A new study finds that sleep timing is linked to dementia risk, as people with weak circadian rhythms face a 2.5 times higher ...

In this issue of the journal, Shoji et al showed that isolated non-specific ST-segment and T-wave abnormalities (NSSTTAs) are associated with incident heart failure (HF).1 The authors conducted a ...

Explore the latest advancements in heart screening with AI models that enhance ECG interpretation for better patient outcomes ...

A screenshot from a video demonstrating how to use the HeartBeam ECG device. HeartBeam (Nasdaq:BEAT) announced today that it received FDA 510(k) clearance for its 12-lead electrocardiogram (ECG) ...

HeartBeam (NASDAQ: BEAT) has been initiated with a Buy rating and $4 price target by Roth Capital Partners, which highlighted the company’s near-term catalyst of expected FDA clearance for its ...

HeartBeam (NASDAQ: BEAT) was featured in a recent article that discussed its development of a portable, credit-card-sized device and proprietary software capable of capturing heart signals in three ...